Exchange: NASDAQ·Updated 09:36 AM EDT

CUVL Clinuvel Pharmaceuticals Ltd - ADR

$6.23
$0.07
(1.14%)
Today
EarningsFeb 23
Mkt Cap$310.64M
Vol1,052.00

About CUVL

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
34

Bearish Sentiment

How do you feel about CUVL?

Advertisement|Remove ads.